» Articles » PMID: 9440563

Tuberculin and Anergy Skin Testing of Patients Receiving Long-term Hemodialysis

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 1998 Jan 24
PMID 9440563
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objectives: Immunocompromised patients with chronic renal failure requiring hemodialysis (HD) are at increased risk of developing tuberculosis (TB). Routine TB screening of this population is recommended. This study examined the frequency of TB reactions and anergy in HD patients in a community with a high prevalence of TB.

Design: Outpatients in a hospital-based HD center were screened with tuberculin, Candida, and mumps antigen.

Results: Forty percent of patients were anergic and 19% were tuberculin reactors. No demographic factors correlated with either test results.

Conclusions: There was a high rate of TB infection and anergy in this HD center. Despite the high rate of anergy, tuberculin testing remains a useful test in this population. Anergic patients require further clinical evaluation for TB. Other HD programs should tuberculin and anergy test their patients to determine prevalence in their populations.

Citing Articles

Incidental lymphadenopathy in renal transplantation.

Ho N, Malik A, Moulding S, Farrow F, Talbot D, White S Ann R Coll Surg Engl. 2023; 106(3):245-248.

PMID: 37489513 PMC: 10904257. DOI: 10.1308/rcsann.2023.0043.


Interferon-gamma release assays for diagnosis of latent TB infection in chronic kidney diseases and dialysis patients.

Hayuk P, Boongird S, Pornsuriyasak P, Bruminhent J Front Cell Infect Microbiol. 2022; 12:1046373.

PMID: 36452296 PMC: 9701719. DOI: 10.3389/fcimb.2022.1046373.


The Dynamic Change of Immune Checkpoints and CD14+ Monocytes in Latent Tuberculosis Infection.

Wang P, Wu M, Hsu C, Lin S, Chang Y, Lee H Biomedicines. 2021; 9(10).

PMID: 34680598 PMC: 8533229. DOI: 10.3390/biomedicines9101479.


Value of gamma interferon enzyme-linked immunospot assay in the diagnosis of peritoneal dialysis-associated tuberculous peritonitis.

Fan Q, Huang X, Zhang J, Sun Y, Xiong Z, Xiong Z Int Urol Nephrol. 2021; 54(4):843-849.

PMID: 34263436 PMC: 8924085. DOI: 10.1007/s11255-021-02960-1.


Completion and Adverse Drug Events of Latent Tuberculosis Infection Treatment in Patients Receiving Dialysis: Predictors and Impacts of Different Regimens in a Prospective Cohort Study.

Lin S, Feng J, Lee C, Lin Y, Chou Y, Lin K Antimicrob Agents Chemother. 2020; 65(3).

PMID: 33361292 PMC: 8092540. DOI: 10.1128/AAC.02184-20.